This instrument is a notification that the Minister's delegate has exercised discretion under subsection 99ACF(3AA) of the National Health Act 1953 to not apply a first new brand statutory price reduction that would otherwise apply to the specified drugs on 1 April 2020.
|
Administered by: Health and Aged Care
|